Synapse - Works

Results (5712)

COVID-19 related outcomes for hospitalized patients (pts) with solid malignancies (SM)

Meeting Abstract

Chi, J.; Chitty, D.; Kohn, N.; Shen, J.; Lopez, C. A.; Hines, A.; Wu, V.; Yang, J. I.; Goldberg, B. H.; Saif, W. M.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

KEYNOTE-555 Cohort B: Efficacy, safety, and PK of pembrolizumab (pembro) 400 mg every 6 weeks (Q6W) as 1L therapy for advanced melanoma

Meeting Abstract

Jacobs, C. R.; Rapoport, B. L.; Chan, S. W.; Ruff, P.; Arance, A. M.; Mujika, K.; Anderson, J. R.; Lala, M.; Jain, L.; Akala, O. O.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer - A randomized, double-blind, placebo-controlled, phase 3 study

Meeting Abstract

Janjigian, Y. Y.; Van Cutsem, E.; Muro, K.; Wainberg, Z. A.; Al-Batran, S. E.; Hyung, W. J.; Molena, D.; Evans, B.; Ruscica, D.; Robbins, S. H.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Quality-adjusted time without symptoms of disease progression or toxicity (Q-TWiST) of nivolumab plus cabozantinib (N+C) versus sunitinib (SUN) in treatment-naïve, advanced/metastatic renal cell carcinoma (aRCC): A post-hoc analysis of CheckMate 9ER (CM 9ER) data

Meeting Abstract

Cella, D.; Motzer, R. J.; May, J.; Wallace, J.; Marteau, F.; Kwon, Y.; Rusibamayila, N.; Botteman, M.; Ejzykowicz, F.; Choueiri, T. K.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Trastuzumab deruxtecan (T-DXd) in patients with human epidermal growth factor receptor 2 (HER2)-expressing salivary duct carcinoma: Subgroup analysis of two phase 1 studies

Meeting Abstract

Bando, H.; Kinoshita, I.; Modi, S.; Tsurutani, J.; Bang, Y. J.; Iwata, H.; Sato, Y.; Nakatani, S.; Lee, C. C.; Sugihara, M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Preliminary analysis of a phase 1/2 study of NEXI-001 donor-derived multi-antigen-specific CD8(+) T-cells for the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT)

Meeting Abstract

Al Malki, M.; Vasu, S.; Modi, D.; Perales, M. A.; Bui, D.; Edavana, V.; Kim, S.; Suarez, L.; Oelke, M.; BednÃ¡rik, D.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Phase 1A clinical trial of the first-in-class fascin inhibitor NP-G2-044 evaluating safety and anti-tumor activity in patients with advanced and metastatic solid tumors

Meeting Abstract

Chung, V.; Jhaveri, K. L.; Von Hoff, D. D.; Huang, X. Y.; Garmey, E. G.; Zhang, J.; Tsai, F. Y. C.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma

Meeting Abstract

Khan, N.; Khimani, F.; Shustov, A. R.; Shadman, M.; Ruan, J.; Moskowitz, A. J.; Straus, D. J.; Kumar, A.; Sauter, C. S.; Zelenetz, A. D.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

The Johns Hopkins Molecular Tumor Board Precision Oncology elective for Medical Oncology fellows

Meeting Abstract

Marrone, K.; Tao, J.; Canzoniero, J. V.; Ghanem, P.; Nizialek, E.; Pagel, K.; Karchin, R.; Donehower, R. C.; Anagnostou, V.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Safety and efficacy of letetresgene autoleucel (lete-cel; GSK3377794) in advanced myxoid/round cell liposarcoma (MRCLS) following high lymphodepletion (Cohort 2): Interim analysis

Meeting Abstract

D'Angelo, S. P.; Druta, M.; Van Tine, B. A.; Liebner, D. A.; Schuetze, S.; Hasan, A. N.; Holmes, A. P.; Huff, A.; Kapoor, G. S.; Zajic, S.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save